You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Sleep and sleep conditions

Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia

  • Technology appraisal guidance
  • Reference number: TA77
  • Published:  28 April 2004
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download (PDF)
  • Overview
  • Outcomes and learning
  • Supporting information

Putting NICE guidance on the management of insomnia disorders into practice

Supporting information

Wändell P, Ljunggren G, Carlsson AC (2025) The most common diagnoses in primary care, and changes over time, in the total population of Stockholm, Sweden. BMC Primary Care 26(1): 235.

Hafner M, Romanelli RJ, Yerushalmi E, Troxel WM (2023) The societal and economic burden of insomnia in adults: An international study. Published online: RAND Corporation.

Contact details

Dr Rania Ward

Principal Pharmacist for Sleep Medicine

Email: rania.ward@nhs.net

Qvh.sleepdisordercentre@nhs.net

ISBN: 978-1-4731-9406-9

This page was last updated: 19 March 2026


Previous page Outcomes and learning
Back to top